Monday, July 31, 2017 9:12:40 PM
Marc Tesio is an experienced investment banker who has successfully raised in excess of $50 million of capital for life sciences and other companies. Most recently, he managed a registered direct public offering for Dara Biosciences, Inc., a life science company developing therapeutic treatments for diseases including diabetes. He also acted as financial advisor to ResverLogix, a Canadian biotechnology company that is developing two novel technologies for important global medical markets, and managed a early stage life science investment for Digene Corporation. Prior to his activities in healthcare corporate finance he managed a syndicate desk and oversaw trading and settlements serving international banks and European based institutional portfolio managers. He began his career at Oppenheimer. He holds a degree with honors in Financial Management from Old Dominion University. He serves his local community helping non-profit organizations and enjoys amateur Georgia State athletic competitions and his family in Atlanta. He holds the Series 7, 24, 63 and 79 securities licenses.
FEATURED Element79 Gold Corp Reports Exceptionally High-Grade Results from Lucero • May 14, 2024 7:00 AM
VAYK Added New Manager for Expansion into $64 Billion Domestic Short-term Rental Market • VAYK • May 14, 2024 9:00 AM
Avant Technologies Equipping AI-Managed Data Center with High Performance Computing Systems • AVAI • May 10, 2024 8:00 AM
VAYK Discloses Strategic Conversation on Potential Acquisition of $4 Million Home Service Business • VAYK • May 9, 2024 9:00 AM
Bantec's Howco Awarded $4.19 Million Dollar U.S. Department of Defense Contract • BANT • May 8, 2024 10:00 AM
Element79 Gold Corp Successfully Closes Maverick Springs Option Agreement • ELEM • May 8, 2024 9:05 AM